Next Article in Journal
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study
Next Article in Special Issue
Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave
Previous Article in Journal
BNT162b2 Booster Dose Elicits a Robust Antibody Response in Subjects with Abdominal Obesity and Previous SARS-CoV-2 Infection
Previous Article in Special Issue
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
 
 
Review

Article Versions Notes

Vaccines 2023, 11(12), 1797; https://doi.org/10.3390/vaccines11121797
Action Date Notes Link
article pdf uploaded. 30 November 2023 16:43 CET Version of Record https://www.mdpi.com/2076-393X/11/12/1797/pdf-vor
article xml file uploaded 1 December 2023 03:42 CET Original file -
article xml uploaded. 1 December 2023 03:42 CET Update https://www.mdpi.com/2076-393X/11/12/1797/xml
article pdf uploaded. 1 December 2023 03:42 CET Updated version of record https://www.mdpi.com/2076-393X/11/12/1797/pdf
article html file updated 1 December 2023 03:44 CET Original file https://www.mdpi.com/2076-393X/11/12/1797/html
Back to TopTop